Matricelf (XTAE:MTLF) EPS (Diluted) : ₪ (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Matricelf EPS (Diluted)?

Matricelf's Earnings per Share (Diluted) for the six months ended in . 20 was ₪0.00.

Matricelf's EPS (Basic) for the six months ended in . 20 was ₪0.00.

Matricelf's EPS without NRI for the six months ended in . 20 was ₪0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Matricelf EPS (Diluted) Historical Data

The historical data trend for Matricelf's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf EPS (Diluted) Chart

Matricelf Annual Data

Trend

EPS (Diluted)

Matricelf Semi-Annual Data

EPS (Diluted)

Competitive Comparison of Matricelf's EPS (Diluted)

For the Biotechnology subindustry, Matricelf's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Matricelf's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matricelf's PE Ratio distribution charts can be found below:

* The bar in red indicates where Matricelf's PE Ratio falls into.

Matricelf EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Matricelf's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

Matricelf's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

Matricelf (XTAE:MTLF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Matricelf EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Matricelf's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Matricelf Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (XTAE:MTLF) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Golda Meir 3, Ness Ziona, ISR, 6701838

Website

https://www.matricelf.com

Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf Headlines

No Headlines